[1] |
庄文芳,吴婧,李莉. 华法林给药剂量预测模型的建立与应用[J].检验医学,2013,28(12):1157-1161.
|
[2] |
WADELIUS M,CHEN LY,LINDH JD,et al.The largest prospective warfarin-treated cohort supports genetic forecasting[J]. Blood, 2009,113(4): 784-792.
|
[3] |
庄文芳,吴德沛,王兆钺. 上海地区服用华法林人群相关基因型及非遗传因素对用药剂量的影响[J].中华血液学杂志,2014,35(1):13-17.
|
[4] |
International Warfarin Pharmacogenetics Consortium, KLEIN TE, ALTMAN RB, et al. Estimation of the warfarin dose with clinical and pharmacogenetic data[J]. N Engl J Med, 2009, 360(8): 753-764.
|
[5] |
WEN MS,LEE M,CHEN JJ,et al.Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes[J]. Clin Pharmacol Ther, 2008, 84(1):83-89.
|
[6] |
HUANG SW, CHEN HS,WANG XQ,et al.Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients[J]. Pharmacogenet Genomics,2009,19(3):226-234.
|
[7] |
OHNO M, YAMAMOTO A,ONO A,et al.Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients[J]. Eur J Clin Pharmacol, 2009,65(11):1097-1103.
|
[8] |
许俊堂,胡大一. 华法林的临床应用[J]. 中国医刊,2004,39(10):43-45.
|
[9] |
李杰,刘双. 华法林抗凝治疗剂量的研究进展[J]. 心肺血管病杂志,2012,31(4):496-498.
|
[10] |
祝锦,张微,张伟娟,等.中国汉族人群华法林药物基因组学剂量预测公式比较[J]. 中国药学杂志,2011,59(24):1929-1934.
|
[11] |
谭胜蓝,彭娟,周新民,等. 验证并比较华法林稳定剂量预测模型对中国心脏瓣膜置换术后患者预测准确性[J].中国临床药理学与治疗学,2012,17(9): 1026-1033.
|
[12] |
MIAO L, YANG J, HUANG C, et al.Contribution of age, body weight and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients[J]. Eur J Clin Pharmacol, 2007, 63(12):1135-1141.
|
[13] |
CALDWELL MD, ANAD T, JOHNSON JA, et al.CYP4F2 genetic variant alters required warfarin dose[J]. Blood, 2008, 111(8): 4106-4112.
|
[14] |
MCDDNALD MG, RIEDER MJ, NAKANO M, et al.CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant[J]. Mol Pharmacol, 2009, 75(6): 1337-1346.
|
[15] |
张海燕,方焕荣,杨协清,等. 血浆蛋白C基因多态性与华法林剂量相关性的研究[J]. 中国药学杂志,2012,60(21):1741-1745.
|
[16] |
LIU Y, YANG J, XU Q, et al.Comparative performance of warfarin pharmacogenetic algorithms in Chinese patients[J]. Thromb Res, 2012, 130(3): 435-440.
|
[17] |
姚浩洁,赵志刚,代金玉. 影响华法令药效的药物与食物[J]. 实用心脑肺血管病杂志,2006,14(3):216.
|